TDC
SGNT

Thompson Davis & Co’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Thompson Davis & Co’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-250
Closed -$4K – 1242
2016
Q2 		$4K Buy
+250
New +$3.21K 0.01% 859

Thompson Davis & Co's SGNT Position: Q3 2016 in Review

Thompson Davis & Co sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 250 shares — an estimated $4K sold.

Thompson Davis & Co first reported a position in SGNT in Q2 2016 and held it in 1 quarter. The position peaked at $4K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Thompson Davis & Co reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 250 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $4K.
  • Thompson Davis & Co first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2016 and held it in 1 quarter.
  • Thompson Davis & Co's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $4K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Thompson Davis & Co's 13F filing for Q3 2016, filed 8 Nov 2016.